Jean-Nicolas Vauthey, MD
Surgical Oncology · Houston, TXNPI 1104912989
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $11,501 of the $13,330 with a category attached, or 86.3%. Siemens Medical Solutions USA, Inc. accounts for 86.6% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $11,883 and has fallen 96.7% since, to $392 in 2025.
Across 20 payments — averaging $666.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$12K
- Medtronic$500
- Johnson & Johnson$466
- Integra Lifesciences Corporation$339
- Fujifilm Healthcare Americas Corporation$167
- Intera Oncology, Inc$156
- plus $164 from 3 others
Across 5 payments — averaging $28,685 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Siemens Medical Solutions USA, Inc.$140K
- Fujifilm Healthcare Americas Corporation$4K
What the payments were for
- Travel & lodging$11,50186%
- Food & beverage$1,82914%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 2 | $11,538 |
| Medtronic(2 entities) | 4 | $500 |
| Johnson & Johnson | 4 | $466 |
| Integra Lifesciences Corporation | 4 | $339 |
| Fujifilm Healthcare Americas Corporation | 2 | $167 |
| Intera Oncology, Inc | 1 | $156 |
| Angiodynamics, Inc. | 1 | $87 |
| Olympus America Inc. | 1 | $64 |
| Tactile Systems Technology Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Signia$469
- DERMABOND PRINEO$230
- ECHELON ENDOPATH$230
- INTERA$156
- NON APPLICABLE$139
- Enseal$133
- CODMAN CERTAS$118
- CUSA CLARITY$118
- DURAGEN$118
- DURASEAL EXACT$118
- CODMAN HAKIM PRECISION VALVE$118
- EVARREST$103
- SURGICEL NU-KNIT$103
How this compares
$13,330 in reported general payments places this provider in the 85th percentile of 191 surgical oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Houston
- Merrick RossHouston$216K
- Kelly HuntHouston$104K
- Michael KimHouston$51K
- Jeffrey GershenwaldHouston$50K
- Naruhiko IkomaHouston$48K
- Anthony LucciHouston$41K
- Helmi KhadraHouston$39K
- Hop Tran CaoHouston$32K
- Rosario HwangHouston$25K
- Amanda ArringtonHouston$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.